These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1035 related articles for article (PubMed ID: 19735885)
1. Critical organ preservation in reirradiation brachytherapy by injectable spacer. Kishi K; Sonomura T; Shirai S; Sato M; Tanaka K Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):587-94. PubMed ID: 19735885 [TBL] [Abstract][Full Text] [Related]
2. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer. Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017 [TBL] [Abstract][Full Text] [Related]
3. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy. Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495 [TBL] [Abstract][Full Text] [Related]
4. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region. Richards GM; Tomé WA; Robins HI; Stewart JA; Welsh JS; Mahler PA; Howard SP Breast Cancer Res Treat; 2009 Mar; 114(2):307-13. PubMed ID: 18389365 [TBL] [Abstract][Full Text] [Related]
5. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer. Perera F; Chisela F; Stitt L; Engel J; Venkatesan V Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783 [TBL] [Abstract][Full Text] [Related]
6. Reirradiation of locally recurrent nasopharyngeal carcinoma. Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Godény M; Németh G; Esik O Strahlenther Onkol; 2003 May; 179(5):298-305. PubMed ID: 12740656 [TBL] [Abstract][Full Text] [Related]
7. Partial breast irradiation with interstitial 60CO brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients. Póti Z; Nemeskéri C; Fekésházy A; Sáfrány G; Bajzik G; Nagy ZP; Bidlek M; Sinkovics I; Udvarhelyi N; Liszkay G; Repa I; Galuska L; Trón L; Mayer A; Esik O Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1022-33. PubMed ID: 15001241 [TBL] [Abstract][Full Text] [Related]
11. Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience. Brabham JG; Cardenes HR Am J Clin Oncol; 2009 Aug; 32(4):417-22. PubMed ID: 19451799 [TBL] [Abstract][Full Text] [Related]
12. Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer. Lee LJ; Viswanathan AN Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1192-7. PubMed ID: 22592049 [TBL] [Abstract][Full Text] [Related]
13. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer. Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246 [TBL] [Abstract][Full Text] [Related]
14. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study. Martínez-Monge R; Alcalde J; Concejo C; Cambeiro M; Garrán C Brachytherapy; 2006; 5(1):32-40. PubMed ID: 16563995 [TBL] [Abstract][Full Text] [Related]
15. Feasibility report for retreatment of locally recurrent head-and-neck cancers by combined brachy-chemotherapy using frameless image-guided 3D interstitial brachytherapy. Krempien RC; Grehn C; Haag C; Straulino A; Hensley FW; Kotrikova B; Hofele C; Debus J; Harms W Brachytherapy; 2005; 4(2):154-62. PubMed ID: 15893270 [TBL] [Abstract][Full Text] [Related]
16. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587 [TBL] [Abstract][Full Text] [Related]
17. Treatment of recurrent bronchial carcinoma: the role of high-dose-rate endoluminal brachytherapy. Hauswald H; Stoiber E; Rochet N; Lindel K; Grehn C; Becker HD; Debus J; Harms W Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):373-7. PubMed ID: 19836162 [TBL] [Abstract][Full Text] [Related]
18. Pilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: clinical experience and dose-volume histogram analysis. Weitmann HD; Pötter R; Waldhäusl C; Nechvile E; Kirisits C; Knocke TH Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):468-78. PubMed ID: 15890589 [TBL] [Abstract][Full Text] [Related]
19. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy. Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267 [TBL] [Abstract][Full Text] [Related]
20. Interstitial high-dose-rate brachytherapy in the treatment of base of tongue carcinoma. Takácsi-Nagy Z; Polgár C; Oberna F; Somogyi A; Major T; Remenár E; Fodor J; Kásler M; Németh G Strahlenther Onkol; 2004 Dec; 180(12):768-75. PubMed ID: 15592696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]